The Incidence and Risk Factors of Renal Insufficiency among Korean HIV infected Patients: The Korea HIV/AIDS Cohort Study

키워드

참고문헌 (20)

1. Cohen SD, "Kidney diseases associated with human immunodeficiency virus infection", N Engl J Med, 377, pp.2363~2374 (2017)
2. Cheung J, "Chronic kidney disease in Australian human immunodeficiency virus-infected patients: analysis of the Australian HIV observational database", Nephrology(Carlton), 23, pp.778~786 (2018)
3. 김은진, "The Prevalence and Risk Factors of Renal Insufficiency among Korean HIV-Infected Patients: The Korea HIV", AIDS Cohort Study, 2017, pp.49(3), 194~204[DOI]
4. GBD 2015 HIV Collaborators, "Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015 : the Global Burden of Disease Study 2015", Lancet HIV, 3, pp.e361~e387 (2016)
5. Boender TS, "AIDS Therapy Evaluation in the Netherlands(ATHENA)national observational HIV cohort : cohort profile", BMJ Open, 8, pp.e022516~ (2018)
6. Cho Yoon-Min, "Assessment of Human Immunodeficiency Virus Care Continuum in Korea using the National Health Insurance System Data", Infection and Chemotherapy, 53(3), pp.477~488 (2021), 대한감염학회[DOI]
7. Smith CJ, "Trends in underlying causes of death in people with HIV from 1999 to 2011(D : A : D) : a multicohort collaboration", Lancet, 384, pp.241~248 (2014)
8. 최보율, "Korea HIV", AIDS Cohort Study: study design and baseline characteristics, 2018, pp.40, 1~8[DOI]
9. Shi R, "Incidence of impaired kidney function among people with HIV : a systematic review and meta-analysis", BMC Nephrol, 23, pp.107~ (2022)
10. Kaboré NF, "Chronic kidney disease and HIV in the era of antiretroviral treatment : findings from a 10-year cohort study in a west African setting", BMC Nephrol, 20, pp.155~ (2019)
11. Quesada PR, "Incidence and risk factors for tenofovir-associated renal toxicity in HIV-infected patients", Int J Clin Pharm, 37, pp.865~872 (2015)
12. Joshi K, "Changes in renal function with longterm exposure to antiretroviral therapy in HIV-infected adults in Asia", Pharmacoepidemiol Drug Saf, 27, pp.1209~1216 (2018)
13. 이민정, "Trends in the Incidence, Prevalence, and Mortality of End-Stage Kidney Disease in South Korea", Diabetes and Metabolism Journal, 44(6), pp.933~937 (2020), 대한당뇨병학회[DOI]
14. Abraham AG, "End-stage renal disease among HIV-infected adults in North America", Clin Infect Dis, 60, pp.941~949 (2015)
15. Tourret J, "Tenofovir effect on the kidneys of HIV-infected patients : a doubleedged sword?", J Am Soc Nephrol, 24, pp.1519~1527 (2013)
16. Suzuki S, "Effect of tenofovir disoproxil fumarate on incidence of chronic kidney disease and rate of estimated glomerular filtration rate decrement in HIV-1-infected treatment-naïve Asian patients : results from 12-year observational cohort", AIDS Patient Care STDS, 31, pp.105~112 (2017)
17. Gupta SK, "Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate : a pooled analysis of 26 clinical trials", AIDS, 33, pp.1455~1465 (2019)
18. Pelchen-Matthews A, "Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort", AIDS, 32, pp.2405~2416 (2018)
19. Chang Hyun-Ha, "Weight Gain and Metabolic Syndrome in Human Immunodeficiency Virus Patients", Infection and Chemotherapy, 54(2), pp.220~235 (2022), 대한감염학회[DOI]
20. Malvestutto CD, "Management of dyslipidemia in HIV-infected patients", Clin Lipidol, 6, pp.447~462 (2011)

관련 논문AI추천